Cargando…

Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma

A20FMDV2 is a 20-mer peptide that exhibits high selectivity and affinity for the tumour-related αvβ6 integrin that can compete with extracellular ligands for the crucial RGD binding site, playing a role as a promising αvβ6-specific inhibitor for anti-cancer therapies. Unfortunately, the clinical val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Kuo-yuan, Kowalczyk, Renata, Desai, Ami, Brimble, Margaret A., Marshall, John F., Harris, Paul W. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316855/ https://www.ncbi.nlm.nih.gov/pubmed/35889207 http://dx.doi.org/10.3390/molecules27144331

Ejemplares similares

A comparison of (64)Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α(ν)β(6)
por: Huynh, Truc T., et al.
Publicado: (2022)

Use of Protein Pegylation to Prolong the Antiviral Effect of IFN Against FMDV
por: Diaz-San Segundo, Fayna, et al.
Publicado: (2021)

Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells
por: Luo, Jihuai, et al.
Publicado: (2011)

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
por: Ichihara, Masako, et al.
Publicado: (2010)

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
por: Burrows, Natalie, et al.
Publicado: (2016)

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
por: Chang, Kwang-Yu, et al.
Publicado: (2021)

Clinical quantification of the integrin αvβ6 by [(18)F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
por: Lukey, Pauline T., et al.
Publicado: (2019)

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy
por: Su, Yu-Cheng, et al.
Publicado: (2017)

Data on the removal of peroxides from functionalized polyethylene glycol (PEG) and effects on the stability and sensitivity of resulting PEGylated conjugates
por: Babity, Samuel, et al.
Publicado: (2020)

Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1
por: Yin, Chunsheng, et al.
Publicado: (2014)

IRES-mediated translation of foot-and-mouth disease virus (FMDV) in cultured cells derived from FMDV-susceptible and -insusceptible animals
por: Kanda, Takehiro, et al.
Publicado: (2016)

PEGylation of Goldbody: PEG-aided conformational engineering of peptides on gold nanoparticles
por: Gao, Tiange, et al.
Publicado: (2022)

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
por: Yang, T-S, et al.
Publicado: (2010)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
por: Yoshinaga, Naoto, et al.
Publicado: (2021)

A gold nanoparticle strip for simultaneously evaluating FMDV immunized antibody level and discriminating FMDV vaccinated animals from infected animals
por: Yang, Suzhen, et al.
Publicado: (2019)

Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
por: Fang, Yan, et al.
Publicado: (2017)

Safety of PEGylated recombinant human full‐length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates
por: Stidl, R., et al.
Publicado: (2015)

Preclinical evaluation of [(18)F]FB-A20FMDV2 as a selective marker for measuring α(V)β(6) integrin occupancy using positron emission tomography in rodent lung
por: Onega, Mayca, et al.
Publicado: (2020)

Intranasal Delivery of Cationic PLGA Nano/Microparticles- Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge
por: Wang, Gang, et al.
Publicado: (2011)

Therapeutic Efficacy of (177)Lu-Labeled A20FMDV2 Peptides Targeting α(ν)β(6)
por: Huynh, Truc Thao, et al.
Publicado: (2022)

Integrins in disguise - mechanosensors in Saccharomyces cerevisiae as functional integrin analogues
por: Elhasi, Tarek, et al.
Publicado: (2019)

On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy
por: Zhu, Yueqiang, et al.
Publicado: (2019)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
por: Chen, Yao, et al.
Publicado: (2018)

FMDV replicons encoding green fluorescent protein are replication competent
por: Tulloch, Fiona, et al.
Publicado: (2014)

Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro
por: Theerawatanasirikul, Sirin, et al.
Publicado: (2021)

Peptide Lipidation – A Synthetic Strategy to Afford Peptide Based Therapeutics
por: Kowalczyk, Renata, et al.
Publicado: (2017)

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
por: Lin, Wen-Wei, et al.
Publicado: (2021)

Impact of Large Aggregated Uricases and PEG Diol on Accelerated Blood Clearance of PEGylated Canine Uricase
por: Zhang, Chun, et al.
Publicado: (2012)

PEGylation of Octreotide Using an α,β-unsaturated-β′-mono-sulfone Functionalized PEG Reagent
por: Erfani-Jabarian, Laleh, et al.
Publicado: (2012)

Protein Coexpression Using FMDV 2A: Effect of “Linker” Residues
por: Minskaia, Ekaterina, et al.
Publicado: (2013)

Peptides Interfering 3A Protein Dimerization Decrease FMDV Multiplication
por: González-Magaldi, Mónica, et al.
Publicado: (2015)

Functional advantages of triplication of the 3B coding region of the FMDV genome
por: Adeyemi, Oluwapelumi O., et al.
Publicado: (2020)

Evaluation of Potential In Vitro Recombination Events in Codon Deoptimized FMDV Strains
por: Spinard, Edward, et al.
Publicado: (2023)

(F)uridylylated Peptides Linked to VPg1 of Foot-and- Mouth Disease Virus (FMDV): Design, Synthesis and X-Ray Crystallography of the Complexes with FMDV RNA-Dependent RNA Polymerase
por: de Castro, Sonia, et al.
Publicado: (2019)

Normal Insulin Secretion from Immune-Protected Islets of Langerhans by PEGylation and Encapsulation in the Alginate-Chitosan-PEG
por: Najafikhah, Nahid, et al.
Publicado: (2018)

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent
por: Deng, Li-Hua, et al.
Publicado: (2021)

Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
por: Sandoughdaran, Saleh, et al.
Publicado: (2015)

Unravelling Selection Shifts Among Foot-and-Mouth Disease Virus (FMDV) Serotypes
por: Tully, Damien C., et al.
Publicado: (2007)

Apigenin Restricts FMDV Infection and Inhibits Viral IRES Driven Translational Activity
por: Qian, Suhong, et al.
Publicado: (2015)

Economic Assessment of FMDv Releases from the National Bio and Agro Defense Facility
por: Pendell, Dustin L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1offh7s52c0qvjk9ittthul43p